4-diphenylacetoxy-1,1-dimethylpiperidinium has been researched along with Airway Obstruction in 1 studies
4-diphenylacetoxy-1,1-dimethylpiperidinium: muscarinic receptor antagonist; RN given refers to parent cpd; do not confuse abbreviation 4-DAMP with a similar cpd which does not contain dimethyl groups
4-DAMP(1+) : A quaternary ammonium salt obtained by formal methylation of the tertiary amino function of 4-diphenylacetoxy-N-methylpiperidine.
Airway Obstruction: Any hindrance to the passage of air into and out of the lungs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Böhm, M | 1 |
| Gengenbach, S | 1 |
| Hauck, RW | 1 |
| Sunder-Plassmann, L | 1 |
| Erdmann, E | 1 |
1 other study available for 4-diphenylacetoxy-1,1-dimethylpiperidinium and Airway Obstruction
| Article | Year |
|---|---|
Beta-adrenergic receptors and m-cholinergic receptors in human lung. Findings following in vivo and in vitro exposure to the beta-adrenergic receptor agonist, terbutaline.
Topics: Aged; Aged, 80 and over; Airway Obstruction; Dose-Response Relationship, Drug; Down-Regulation; Elec | 1991 |